The Global To Stupefy Growth Of The Neurovascular Thrombectomy Devices Market

Posted by Merin John on May 3rd, 2021

Thrombectomy is a surgical procedure to remove the blood clots formed in the blood vessel. Cerebral infraction is an ischemic stroke that results in lack of blood supply to the brain. Neurovascular thrombectomy devices also known as cerebral thrombectomy devices are used to retrieve or destroy the blood clots in the cerebral region.

The blockage in blood vessels of the brain is due to various reasons, such as atheroma, an embolus or a thrombus of one or more arteries. The blood clot formed may lead to draining or leakage of blood into the brain, if left untreated.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/26176

Company Profiles

Medtronic Plc

Stryker Corporation

Teleflex Incorporated

Terumo Corporation

Johnson & Johnson Services, Inc.

Penumbra Inc.

Boston Scientific Corporation

Edwards Lifesciences Corporation

Acandis GmbH

Argon Medical Inc

More than 90% of strokes are of cerebral infarction in the U.S. According to the Centers for Disease Control and Prevention (CDC), around 130,000 deaths in the Americas are due to strokes every year. The World Health Organization claims that one death due to stroke occurs in every 10 seconds around the world.

The risk associated with cerebral infraction are diabetes, high blood pressure, excessive smoking, hyperlipoproteinemia, atherosclerosis, obesity and hypercholesterolemia.

The growing prevalence and incidence of cerebral infraction is projected to fuel the demand for neurovascular thrombectomy devices. Increasing number of patients suffering from ischemic stroke worldwide is also expected to boost the adoption of neurovascular thrombectomy devices.

Rapid disease intervention and better device penetration in market could fuel growth of the global neurovascular thrombectomy devices market during the forecast period. Increasing prevalence and intervention of sickle cell anemia could also boost revenue growth of neurovascular thrombectomy devices market.

These neurovascular thrombectomy devices are also used in patients where pharmacological treatment has not worked effectively. Use of neurovascular thrombectomy devices in patients with thrombolysis are more effective.

Like it? Share it!


Merin John

About the Author

Merin John
Joined: December 11th, 2020
Articles Posted: 262

More by this author